CerraCap Ventures invests in Breezy Med to Accelerate Hospital Automation
Breezy Med is proud to announce a strategic investment from CerraCap Ventures, a leading early-stage venture capital firm focused on enterprise, healthcare, and cybersecurity technologies. This partnership marks a major milestone in Breezy Med’s mission to modernize infection prevention and environmental hygiene in healthcare.
Cerracap’s investment strengthens Breezy Med’s ability to scale its hospital-focused disinfection systems and cloud platform. With growing demand for automated infection control solutions, Breezy Med’s innovative Breezy Blue™ and Breezy Cloud data platform are now positioned to reach more hospitals nationwide—delivering enhanced germicidal performance, improved staff workflows, and actionable usage data.
As hospitals continue to navigate staff shortages, rising HAI risks, and stricter compliance requirements, Breezy Med provides a modern alternative to traditional disinfection approaches. Cerracap’s healthcare expertise and strong network will help accelerate Breezy Med’s expansion into new markets and strategic partnerships, building on early adoption by systems such as Presbyterian Healthcare Services and Sandia National Laboratories.
"We’re thrilled to welcome Cerracap Ventures as a partner in our growth," said Chris Ziomek, CEO of Breezy Med. "Their investment supports our goal to bring effective, easy-to-use automation to hospitals everywhere."
Learn more about Breezy Med’s vision and solutions at breezymed.com.
